Advisory

Investor Relations and Corporate Communications

Equity Research

LifeSci Advisors is a full-service consulting agency for companies in the life sciences. Our veteran team has strong relationships with leaders in the healthcare investment banking, business development, and clinical expert communities. In addition to facilitating specific introductions, we can provide detailed market research to our clients, including end-user surveys.

• 360 review of existing assets and technologies
• Physician surveys and one on one interviews to gain market insights
• Access to proprietary network of 50,000+ experts in 20 countries, including scientists, physicians and former FDA advisory committee members
• Strategies and recommendations to:
• Prioritize opportunities based on core technologies
• Optimize in-house utilization of assets
• Explore sale/licensing of non-strategic assets

• Identify and evaluate products and technologies for in-licensing or out-licensing
• Identify international licensing opportunities (geographies including Europe and Asia)
• Assess market opportunity and competitive landscape for new or existing products
• Review of literature, medical conference presentations, physician interviews
• Preparation of diligence package for product in-licensing/out-licensing
• Prepare marketing materials for use in business development
• Scientific white papers, scientific and business presentations
• Asset valuation analysis/product NPV, valuation of royalty streams
• Preparation of models

As a communications consultancy, LifeSci Advisors offers strategic advice to companies in the life sciences, as well as to advisory and investment firms focusing on these industries. We provide our clients with company-specific and situation-specific IR strategy and planning, which encompasses investment theme positioning and development as well as enhancing relationships with institutional investors. We work with senior management to develop capital markets strategies and communications planning around major news flow and events, including medical and investor conferences.

• Investor presentations, website design, programming and SEO, annual reports, 10k wraps, proxy statements and other year-end filing statements
• Development of style guidelines, logo design, trade advertising and brand strategy
• Preparation of diligence package for M&A and private placements
• Assistance in deal marketing; preparation of research package
• Capital structure advice

• Our team regularly works with clients to draft/edit/review press releases
• We have negotiated bulk, low-cost release distribution rates with major wire services
• We offer US national distribution, which blankets the entire US, hits all the major financials, and has an industry-specific focus
• Complimentary search engine optimization (SEO)
• Unlimited word count
• Complimentary tracking report
• We provide the option to distribute the release in other countries
• We also offer the ability to directly distribute releases (via email) to up to 20K journalists
• Capacity to distribute earnings release and EDGAR filings too

LifeSci Advisors provides equity research to companies specializing in pharmaceutical discovery and development, drug delivery, medical devices and diagnostics. Our team of equity research analysts understands investors’ need for unique insight to support an educated investment decision. Led by Wall Street veteran, Andrew McDonald, our seasoned analysts meticulously research fundamentals, focusing on corporate and scientific milestones, to produce thoughtful, objective and comprehensive evaluations of each company’s investment thesis. We stay up to date and communicate the latest developments in each client’s universe. This model has been embraced by the financial community as the logical evolution of sell-side research.